Eran Ovadya, Chief Financial Officer of NurExone stated, “The ISCT 2025 conference is a key opportunity to showcase our advances and to expand our U.S. presence. As we grow Exo-Top and pursue U.S.

For instance, a biotech firm working on breast cancer treatments, which has nearly 300,000 new cases in the U.S. each year, might be more valuable than a company that is developing drugs for ...

Concord Biotech Ltd., incorporated in the year 1984, is a Small Cap company (having a market cap of Rs 22,091.80 Crore) operating in Pharmaceuticals sector. Concord Biotech Ltd. key Products/Revenue ...

Genomic Valley Biotech Ltd., incorporated in the year 1996, is a Small Cap company (having a market cap of Rs 12.92 Crore) operating in Miscellaneous sector. Genomic Valley Biotech Ltd. key ...

You can change your preferences or opt out of hearing from us at any time using the unsubscribe link in our emails. Read our full privacy notice. Treat yourself or a loved one with the gift of ...